Last reviewed · How we verify
OLODATEROL HYDROCHLORIDE
At a glance
| Generic name | OLODATEROL HYDROCHLORIDE |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
| First approval | 2014 |
Approved indications
Common side effects
Key clinical trials
- A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of TQC3302 Inhalation Spray in Healthy Adult Subjects (PHASE1)
- Ultra-long Acting Bronchodilator Therapy in Smoking Asthmatics (PHASE4)
- An Efficacy Study of Umeclidinium/Vilanterol With Tiotropium/Olodaterol in COPD Patients (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- OLODATEROL HYDROCHLORIDE CI brief — competitive landscape report
- OLODATEROL HYDROCHLORIDE updates RSS · CI watch RSS